Common cold coronaviruses may offer pre-existing immunity to COVID-19

The FDA grant­ed ac­cel­er­at­ed ap­proval to Sarep­ta Ther­a­peu­tics’ Duchenne mus­cu­lar dy­s­tro­phy gene ther­a­py for boys aged 4 and 5 in a de­ci­sion that al­lows ac­cess

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.)   Em­ploy­ers, in­sur­ers and in­vestors have long been